Ku Regulates the Non-Homologous End Joining Pathway Choice of DNA Double-Strand Break Repair in Human Somatic Cells

por Fattah, Farjana, Lee, Eu Han, Weisensel, Natalie, Wang, Yongbao, Lichter, Natalie, Hendrickson, Eric A.
Publicado 2010

XRN2 interactome reveals its synthetic lethal relationship with PARP1 inhibition

por Patidar, Praveen L., Viera, Talysa, Morales, Julio C., Singh, Naveen, Motea, Edward A., Khandelwal, Megha, Fattah, Farjana J.
Publicado 2020

The Kub5-Hera/RPRD1B interactome: a novel role in preserving genetic stability by regulating DNA mismatch repair

por Patidar, Praveen L., Motea, Edward A., Fattah, Farjana J., Zhou, Yunyun, Morales, Julio C., Xie, Yang, Garner, Harold R., Boothman, David A.
Publicado 2016

The Transcription Factor TFII-I Promotes DNA Translesion Synthesis and Genomic Stability

por Fattah, Farjana J., Hara, Kodai, Fattah, Kazi R., Yang, Chenyi, Wu, Nan, Warrington, Ross, Chen, David J., Zhou, Pengbo, Boothman, David A., Yu, Hongtao
Publicado 2014

Divergent prognostic effects of pre-existing and treatment-emergent thyroid dysfunction in patients treated with immune checkpoint inhibitors

por von Itzstein, Mitchell S., Gonugunta, Amrit S., Wang, Yiqing, Sheffield, Thomas, Lu, Rong, Ali, Sadia, Fattah, Farjana J., Xie, Donglu, Cai, Jennifer, Xie, Yang, Gerber, David E.
Publicado 2022

Correction to: Divergent prognostic effects of pre-existing and treatment-emergent thyroid dysfunction in patients treated with immune checkpoint inhibitors

por von Itzstein, Mitchell S., Gonugunta, Amrit S., Wang, Yiqing, Sheffield, Thomas, Lu, Rong, Ali, Sadia, Fattah, Farjana J., Xie, Donglu, Cai, Jennifer, Xie, Yang, Gerber, David E.
Publicado 2022

Immune dysregulation in cancer patients developing immune-related adverse events

por Khan, Shaheen, Khan, Saad A., Luo, Xin, Fattah, Farjana J., Saltarski, Jessica, Gloria-McCutchen, Yvonne, Lu, Rong, Xie, Yang, Li, Quan, Wakeland, Edward, Gerber, David E.
Publicado 2018

T-cell tolerant fraction as a predictor of immune-related adverse events

por Ostmeyer, Jared, Park, Jason Y, von Itzstein, Mitchell S, Hsiehchen, David, Fattah, Farjana, Gwin, Mary, Catalan, Rodrigo, Khan, Shaheen, Raj, Prithvi, Wakeland, Edward K, Xie, Yang, Gerber, David E
Publicado 2023

Kub5-Hera, the human Rtt103 homolog, plays dual functional roles in transcription termination and DNA repair

por Morales, Julio C., Richard, Patricia, Rommel, Amy, Fattah, Farjana J., Motea, Edward A., Patidar, Praveen L., Xiao, Ling, Leskov, Konstantin, Wu, Shwu-Yuan, Hittelman, Walter N., Chiang, Cheng-Ming, Manley, James L., Boothman, David A.
Publicado 2014

Humoral and cellular correlates of a novel immune-related adverse event and its treatment

por Gonugunta, Amrit S, von Itzstein, Mitchell S, Mu-Mosley, Hong, Fattah, Farjana, Farrar, J David, Mobely, Angela, Rashdan, Sawsan, Lai, Sunny, Bhai, Salman F, Bermas, Bonnie L, Karp, David, Li, Quan-Zhen, Wakeland, Edward K, Gerber, David E
Publicado 2021

Late‐Onset Immunotherapy Toxicity and Delayed Autoantibody Changes: Checkpoint Inhibitor–Induced Raynaud's‐Like Phenomenon

por Khan, Shaheen, von Itzstein, Mitchell S., Lu, Rong, Bermas, Bonnie L., Karp, David R., Khan, Saad A., Fattah, Farjana J., Park, Jason Y., Saltarski, Jessica M., Gloria‐McCutchen, Yvonne, Xie, Yang, Li, Quan‐Zhen, Wakeland, Edward K., Gerber, David E.
Publicado 2020

Systemic immune parameters after prior radiation therapy in patients receiving immune checkpoint inhibitors

por Mundra, Vatsala, Yang, Yuqiu, von Itzstein, Mitchell S., Fattah, Farjana, Gonugunta, Amrit S., Hannan, Raquibul, Pop, Laurentiu M., Zhang, Yuanyuan, Wang, Yiqing, Sheffield, Thomas, Xie, Yang, Dowell, Jonathan E., Homsi, Jade, Rashdan, Sawsan, Park, Jason, Li, Quan-Zhen, Wakeland, Edward K., Gerber, David E.
Publicado 2023

Association between body mass index, dosing strategy, and efficacy of immune checkpoint inhibitors

por Ahmed, Murtaza, von Itzstein, Mitchell S, Sheffield, Thomas, Khan, Shaheen, Fattah, Farjana, Park, Jason Y, Popat, Vinita, Saltarski, Jessica M, Gloria-McCutchen, Yvonne, Hsiehchen, David, Ostmeyer, Jared, Khan, Saad A, Sultana, Nazima, Xie, Yang, Li, Quan-Zhen, Wakeland, Edward K, Gerber, David E
Publicado 2021

Phase 1 study of ARQ 761, a β-lapachone analogue that promotes NQO1-mediated programmed cancer cell necrosis

por Gerber, David E., Beg, M. Shaalan, Fattah, Farjana, Frankel, Arthur E., Fatunde, Oluwatomilade, Arriaga, Yull, Dowell, Jonathan E., Bisen, Ajit, Leff, Richard D., Meek, Claudia C., Putnam, William C., Kallem, Raja Reddy, Subramaniyan, Indhumathy, Dong, Ying, Bolluyt, Joyce, Sarode, Venetia, Luo, Xin, Xie, Yang, Schwartz, Brian, Boothman, David A.
Publicado 2018

Association between Antibiotic Exposure and Systemic Immune Parameters in Cancer Patients Receiving Checkpoint Inhibitor Therapy

por von Itzstein, Mitchell S., Gonugunta, Amrit S., Sheffield, Thomas, Homsi, Jade, Dowell, Jonathan E., Koh, Andrew Y., Raj, Prithvi, Fattah, Farjana, Wang, Yiqing, Basava, Vijay S., Khan, Shaheen, Park, Jason Y., Popat, Vinita, Saltarski, Jessica M., Gloria-McCutchen, Yvonne, Hsiehchen, David, Ostmeyer, Jared, Xie, Yang, Li, Quan-Zhen, Wakeland, Edward K., Gerber, David E.
Publicado 2022